Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/7206| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Potpara, Tatjana S | en_US |
| dc.contributor.author | Poposka, Lidija | en_US |
| dc.date.accessioned | 2020-03-10T08:26:55Z | - |
| dc.date.available | 2020-03-10T08:26:55Z | - |
| dc.date.issued | 2018 | - |
| dc.identifier.uri | http://hdl.handle.net/20.500.12188/7206 | - |
| dc.description.abstract | The incidence of cancer-related venous thromboembolism (VTE) is high, has increased in recent decades (likely owing to better awareness of the syndrome, diagnostic improvements and better treatment strategies with longer survival of cancer patients) and is associated with increased risk of recurrent events and high mortality. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Georg Thieme Verlag KG | en_US |
| dc.relation.ispartof | Thrombosis and Haemostasis | en_US |
| dc.subject | Thromboprophylaxis | en_US |
| dc.subject | Cancer Patients | en_US |
| dc.subject | Balancing the Thrombotic and Bleeding Risks | en_US |
| dc.title | The Challenge of Thromboprophylaxis in Cancer Patients-Balancing the Thrombotic and Bleeding Risks | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.1055/s-0038-1667151 | - |
| dc.identifier.url | http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0038-1667151.pdf | - |
| dc.identifier.volume | 118 | - |
| dc.identifier.issue | 8 | - |
| dc.identifier.fpage | 1347 | - |
| dc.identifier.lpage | 1349 | - |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| crisitem.author.dept | Faculty of Medicine | - |
| Appears in Collections: | Faculty of Medicine: Journal Articles | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.